{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:08:06Z","timestamp":1790712486169,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T00:00:00Z","timestamp":1416009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11046-014-9831-8","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T16:13:04Z","timestamp":1415981584000},"page":"213-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The A395T Mutation in ERG11 Gene Confers Fluconazole Resistance in Candida tropicalis Causing Candidemia"],"prefix":"10.1007","volume":"179","author":[{"given":"Jingwen","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"key":"9831_CR1","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","volume":"50","author":"SR Lockhart","year":"2012","unstructured":"Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from, 2008 to 2011. J Clin Microbiol. 2012;50:3435\u201342.","journal-title":"J Clin Microbiol"},{"key":"9831_CR2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","volume":"49","author":"MC Arendrup","year":"2011","unstructured":"Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol. 2011;49:325\u201334.","journal-title":"J Clin Microbiol"},{"key":"9831_CR3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ijantimicag.2012.07.022","volume":"40","author":"CY Chen","year":"2012","unstructured":"Chen CY, Huang SY, Tsay W, Yao M, Tang JL, Ko BS, et al. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001\u20132010. Int J Antimicrob Agents. 2012;40:533\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"9831_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","volume":"2","author":"D Sanglard","year":"2002","unstructured":"Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis. 2002;2:73\u201385.","journal-title":"Lancet Infect Dis"},{"key":"9831_CR5","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","volume":"115","author":"NV Sipsas","year":"2009","unstructured":"Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009;115:4745\u201352.","journal-title":"Cancer"},{"key":"9831_CR6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10156-012-0412-9","volume":"18","author":"Y Chong","year":"2012","unstructured":"Chong Y, Shimoda S, Yakushiji H, Ito Y, Miyamoto T, Shimono N, et al. Fatal candidemia caused by azole-resistant Candida tropicalis in patients with hematological malignancies. J Infect Chemother. 2012;18:741\u20136.","journal-title":"J Infect Chemother"},{"key":"9831_CR7","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","volume":"48","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48:1366\u201377.","journal-title":"J Clin Microbiol"},{"key":"9831_CR8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503\u201335.","journal-title":"Clin Infect Dis"},{"key":"9831_CR9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","volume":"359","author":"DP Kontoyiannis","year":"2002","unstructured":"Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. Lancet. 2002;359:1135\u201344.","journal-title":"Lancet"},{"key":"9831_CR10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","volume":"11","author":"TC White","year":"1998","unstructured":"White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev. 1998;11:382\u2013402.","journal-title":"Clin Microbiol Rev"},{"key":"9831_CR11","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts-third edition: approved standard M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts-third edition: approved standard M27-A3. Wayne: CLSI; 2008."},{"key":"9831_CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkt330","volume":"69","author":"W Liu","year":"2014","unstructured":"Liu W, Tan J, Sun J, Xu Z, Li M, Yang Q, et al. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study. J Antimicrob Chemother. 2014;69:162\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"9831_CR13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1128\/JCM.35.5.1216-1223.1997","volume":"35","author":"CP Kurtzman","year":"1997","unstructured":"Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5\u2032 end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol. 1997;35:1216\u201323.","journal-title":"J Clin Microbiol"},{"key":"9831_CR14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","volume":"13","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D. CLSI subcommittee for antifungal susceptibility testing. wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat. 2010;13:180\u201395.","journal-title":"Drug Resist Updat"},{"key":"9831_CR15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","volume":"70","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Andes D, Arendrup MC, Diekema DJ, Espinel-Ingroff A, Alexander BD, et al. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis. 2011;70:330\u201343.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"9831_CR16","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA, Espinel-Ingroff A, Canton E, Castanheira M, Cuenca-Estrella M, Diekema DJ, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol. 2012;50:2040\u20136.","journal-title":"J Clin Microbiol"},{"key":"9831_CR17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1179\/joc.2009.21.3.351","volume":"21","author":"AR Costa","year":"2009","unstructured":"Costa AR, Rodrigues ME, Silva F, Henriques M, Azeredo J, Faustino A, et al. MIC evaluation of Candida reference strains and clinical isolates by E-test. J Chemother. 2009;21:351\u20135.","journal-title":"J Chemother"},{"key":"9831_CR18","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1093\/nar\/19.24.6823","volume":"19","author":"J Versalovic","year":"1999","unstructured":"Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1999;19:6823\u201331.","journal-title":"Nucleic Acids Res"},{"key":"9831_CR19","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1093\/nar\/25.24.4876","volume":"25","author":"JD Thompson","year":"1997","unstructured":"Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25:4876\u201382.","journal-title":"Nucleic Acids Res"},{"key":"9831_CR20","doi-asserted-by":"crossref","unstructured":"Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, et al. Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci. 2007; Chapter 2: 2.9.1\u201331.","DOI":"10.1002\/0471140864.ps0209s50"},{"key":"9831_CR21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aided Mol Des. 2010;24:417\u201322.","journal-title":"J Comput Aided Mol Des"},{"key":"9831_CR22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jac\/42.2.241","volume":"42","author":"D Sanglard","year":"1998","unstructured":"Sanglard D, Ischer F, Koymans L, Bille J. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother. 1998;42:241\u201353.","journal-title":"Antimicrob Agents Chemother"},{"key":"9831_CR23","first-page":"171","volume":"180","author":"SL Kelly","year":"1999","unstructured":"Kelly SL, Lamb DC, Kelly DE. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol Lett. 1999;180:171\u20135.","journal-title":"FEMS Microbiol Lett"},{"key":"9831_CR24","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.061562898","volume":"98","author":"LM Podust","year":"2001","unstructured":"Podust LM, Poulos TL, Waterman MR. Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA. 2001;98:3068\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9831_CR25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.48.2.568-574.2004","volume":"48","author":"L Xiao","year":"2004","unstructured":"Xiao L, Madison V, Chau AS, Loebenberg D, Palermo RE, McNicholas PM. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob Agents Chemother. 2004;48:568\u201374.","journal-title":"Antimicrob Agents Chemother"},{"key":"9831_CR26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2741\/1639","volume":"10","author":"Y Aoyama","year":"2005","unstructured":"Aoyama Y. Recent progress in the CYP51 research focusing on its unique evolutionary and functional characteristics as a diversozyme P450. Front Biosci. 2005;10:1546\u201357.","journal-title":"Front Biosci"},{"key":"9831_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0006-2952(87)90694-0","volume":"36","author":"Y Yoshida","year":"1987","unstructured":"Yoshida Y, Aoyama Y. Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes. Biochem Pharmacol. 1987;36:229\u201335.","journal-title":"Biochem Pharmacol"},{"key":"9831_CR28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1042\/bst0190778","volume":"19","author":"Y Yoshida","year":"1991","unstructured":"Yoshida Y, Aoyama Y. Sterol 14 alpha-demethylase and its inhibition: structural considerations on interaction of azole antifungal agents with lanosterol 14 alpha-demethylase (P-450(14DM)) of yeast. Biochem Soc Trans. 1991;19:778\u201382.","journal-title":"Biochem Soc Trans"},{"key":"9831_CR29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","volume":"397","author":"N Strushkevich","year":"2010","unstructured":"Strushkevich N, Usanov SA, Park HW. Structural basis of human CYP51 inhibition by antifungal azoles. J Mol Biol. 2010;397:1067\u201378.","journal-title":"J Mol Biol"},{"key":"9831_CR30","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1021\/jm990589g","volume":"43","author":"H Ji","year":"2000","unstructured":"Ji H, Zhang W, Zhou Y, Zhang M, Zhu J, Song Y, et al. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals. J Med Chem. 2000;43:2493\u2013505.","journal-title":"J Med Chem"},{"key":"9831_CR31","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/AEM.63.8.2966-2970.1997","volume":"63","author":"C Delye","year":"1997","unstructured":"Delye C, Laigret F, Corio-Costet MF. A mutation in the 14 alpha-demethylase gene of Uncinula necator that correlates with resistance to a sterol biosynthesis inhibitor. Appl Environ Microbiol. 1997;63:2966\u201370.","journal-title":"Appl Environ Microbiol"},{"key":"9831_CR32","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1128\/AAC.49.11.4608-4615.2005","volume":"49","author":"P Vandeputte","year":"2005","unstructured":"Vandeputte P, Larcher G, Berg\u00e8s T, Renier G, Chabasse D, Bouchara JP. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother. 2005;49:4608\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"9831_CR33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jac\/dks481","volume":"68","author":"C Jiang","year":"2013","unstructured":"Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother. 2013;68:778\u201385.","journal-title":"J Antimicrob Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-014-9831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-014-9831-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-014-9831-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T20:37:21Z","timestamp":1598474241000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-014-9831-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,15]]},"references-count":33,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["9831"],"URL":"https:\/\/doi.org\/10.1007\/s11046-014-9831-8","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,15]]}}}